Vascular Endothelial Growth Factors
"Vascular Endothelial Growth Factors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A family of angiogenic proteins that are closely-related to VASCULAR ENDOTHELIAL GROWTH FACTOR A. They play an important role in the growth and differentiation of vascular as well as lymphatic endothelial cells.
| Descriptor ID |
D042442
|
| MeSH Number(s) |
D12.644.276.100.800 D12.776.467.100.800 D23.529.100.800
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Vascular Endothelial Growth Factors".
Below are MeSH descriptors whose meaning is more specific than "Vascular Endothelial Growth Factors".
This graph shows the total number of publications written about "Vascular Endothelial Growth Factors" by people in this website by year, and whether "Vascular Endothelial Growth Factors" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 |
| 1997 | 0 | 2 | 2 |
| 1998 | 0 | 3 | 3 |
| 1999 | 0 | 7 | 7 |
| 2000 | 0 | 5 | 5 |
| 2001 | 0 | 6 | 6 |
| 2002 | 0 | 6 | 6 |
| 2003 | 0 | 2 | 2 |
| 2004 | 1 | 0 | 1 |
| 2005 | 3 | 0 | 3 |
| 2010 | 1 | 0 | 1 |
| 2012 | 2 | 0 | 2 |
| 2018 | 1 | 0 | 1 |
| 2020 | 1 | 0 | 1 |
| 2021 | 1 | 1 | 2 |
| 2022 | 0 | 1 | 1 |
| 2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Vascular Endothelial Growth Factors" by people in Profiles.
-
Treatment Strategies for Anti-VEGF Resistance in Neovascular Age-Related Macular Degeneration by Targeting Arteriolar Choroidal Neovascularization. Biomolecules. 2024 02 21; 14(3).
-
Notch1 signaling in keratocytes maintains corneal transparency by suppressing VEGF expression. Stem Cell Reports. 2022 06 14; 17(6):1442-1457.
-
The relationship between vascular endothelial growth factor (VEGF) and amnestic mild cognitive impairment among older adults living with HIV. J Neurovirol. 2021 12; 27(6):885-894.
-
Epicardial delivery of XC001 gene therapy for refractory angina coronary treatment (The EXACT Trial): Rationale, design, and clinical considerations. Am Heart J. 2021 11; 241:38-49.
-
miR-18a Inhibits BMP4 and HIF-1a Normalizing Brain Arteriovenous Malformations. Circ Res. 2020 10 09; 127(9):e210-e231.
-
Targeted therapy in bone and soft tissue sarcoma in children and adolescents. Curr Oncol Rep. 2012 Apr; 14(2):197-205.
-
Circulating vascular growth factors and central hemodynamic load in the community. Hypertension. 2012 Apr; 59(4):773-9.
-
Astrocyte pVHL and HIF-a isoforms are required for embryonic-to-adult vascular transition in the eye. J Cell Biol. 2011 Nov 14; 195(4):689-701.
-
ZIP4 upregulates the expression of neuropilin-1, vascular endothelial growth factor, and matrix metalloproteases in pancreatic cancer cell lines and xenografts. Cancer Biol Ther. 2010 Feb; 9(3):236-42.
-
Molecular correlates of gefitinib responsiveness in human bladder cancer cells. Mol Cancer Ther. 2007 Jan; 6(1):277-85.